Orthofix Welcomes New Board Chair

Orthofix Medical Inc. has welcomed a new board chair.

Catherine Burzik has been nominated to head the governing body, replacing Ron Matricaria, chairman for the past seven years, who has decided not to stand for re-election so he can focus on other personal and business commitments. Burzik has more than 30 years of experience as a senior executive and board member of major medical device, diagnostic and life sciences businesses. In addition, Maria Sainz, who has served 12 cumulative years as a director, has decided not to stand for re-election at the Annual Meeting in order to focus on her own personal and business commitments, and the size of the board will be reduced from nine to eight seats in connection with her departure as a director.
 
“I am honored to have led Orthofix as chair of the board and to have worked with so many dedicated individuals who truly care about bringing quality medical devices and solutions to the market,” said Matricaria. “When I joined the company, my goal was to help shape it for the years to come, leaving it stronger and well-positioned for the road ahead. Orthofix has a very bright future, and I am confident that Cathy’s vast healthcare experience will provide the Orthofix board valuable leadership and insights as the company continues its mission to deliver innovative, quality-driven solutions to improve the lives of patients around the world.”
 
Burzik previously served as president and CEO of Kinetic Concepts Inc., a global medical device company, from 2006 until the company’s sale in 2011. Prior to this, she served as president of Applied Biosystems Group and held senior executive positions at Eastman Kodak and Johnson & Johnson, including CEO and president of Kodak Health Imaging Systems and president of Ortho-Clinical Diagnostics Inc., a Johnson & Johnson company. In 2019, Burzik received the AdvaMed Lifetime Achievement Award that honors accomplishments of pioneers in the medical technology industry whose contributions have had a significant impact on patients’ lives and the industry as an essential part of America’s economy.

“My career has been devoted to advancing the healthcare industry and I would be honored to be a part of Orthofix,” said Burzik. “The opportunity to step into the role of chair of the Orthofix Board of Directors is exciting given how well-positioned I believe the company is for growth. It would be very rewarding to work with such a talented group of leaders to continue to advance the progress the company is making in the delivery of meaningful life-changing technologies.”
 
Currently Burzik is a member of the Board of Directors of Becton, Dickinson and Company, where she chairs the Quality and Regulatory Compliance Committee and serves on the Corporate Governance and Nominating Committee, and the Science, Marketing, Innovation and Technology Committees. Burzik is also a member of the Board of Directors of Haemonetics Corporation where she chairs the Technology Committee and serves on the Audit Committee. Additionally, she serves as executive chairman of Gemini Bioproducts Inc., chairman of StemBioSys Inc., and chairman of the American College of Wound Healing and Tissue Repair. Burzik previously served on the Board of Directors for the San Antonio Branch of the Dallas Federal Reserve Board, Allscripts Inc., Bausch & Lomb, Cordis Corporation, and AdvaMed.
 
“I want to thank Ron and Maria for their years of dedicated service on the Orthofix board. Their guidance has been invaluable to me and the team as we have worked to position Orthofix for the future,” said Orthofix President and CEO Jon Serbousek. “I look forward to welcoming Cathy as the new chair of the Orthofix board upon her election. Her experience across many sectors of the healthcare industry as a senior executive, board member and investor will provide great perspective as we continue building on the capabilities created in 2020 to drive growth and pursue high value solutions for patients, surgeons, and hospitals around the world.”